» Articles » PMID: 15123777

Increased Numbers of Committed Myeloid Progenitors but Not Primitive Hematopoietic Stem/progenitors in Mice Lacking STAT6 Expression

Overview
Journal J Leukoc Biol
Date 2004 May 5
PMID 15123777
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Signal transducer and activator of transcription-6 (STAT6) plays important roles in cytokine signaling via interleukin-4 and -13 receptors (IL-4R and IL-13R). Mice in which STAT6 has been disrupted by homologous recombination show defects in T helper cell type 2 (Th2) lymphocyte production, resulting in an accumulation of Th1 cells. In addition to defects in differentiation and proliferation of T lymphocytes, STAT6-deficient mice show increased cell-cycle activation and frequency of myeloid progenitors. Although this has been shown to be mediated through Oncostatin M production by T cells, IL-4Ralpha and STAT6 have also recently been found to be enriched for expression in primitive hematopoietic stem cells (HSCs) in gene expression-profiling studies. Therefore, we have investigated whether defects in hematopoietic function in mice lacking STAT6 expression extended into the primitive hematopoietic compartments of the bone marrow. Here, we report that STAT6 deficiency increased bone marrow-committed myeloid progenitors but did not alter the number of cells enriched for HSC/multipotent progenitors, primitive cobblestone area-forming cells assayed in vitro, or bone marrow short-term or long-term repopulating cells assayed in vivo. Therefore, the requirement for STAT6 activation during hematopoiesis is limited, and primitive hematopoietic cell types are insulated against possible effects of cytokine stimulation by Th1 cells.

Citing Articles

Uncovering expression signatures of synergistic drug responses via ensembles of explainable machine-learning models.

Janizek J, Dincer A, Celik S, Chen H, Chen W, Naxerova K Nat Biomed Eng. 2023; 7(6):811-829.

PMID: 37127711 PMC: 11149694. DOI: 10.1038/s41551-023-01034-0.


Type 2 innate immunity drives distinct neonatal immune profile conducive for heart regeneration.

Chen F, Tse J, Jin L, Chook C, Leung F, Tse G Theranostics. 2022; 12(3):1161-1172.

PMID: 35154480 PMC: 8771554. DOI: 10.7150/thno.67515.


Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner.

Pena-Martinez P, Eriksson M, Ramakrishnan R, Chapellier M, Hogberg C, Orsmark-Pietras C Leukemia. 2017; 32(3):588-596.

PMID: 28819278 PMC: 5843897. DOI: 10.1038/leu.2017.261.


IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1.

Jenkins S, Ruckerl D, Thomas G, Hewitson J, Duncan S, Brombacher F J Exp Med. 2013; 210(11):2477-91.

PMID: 24101381 PMC: 3804948. DOI: 10.1084/jem.20121999.


Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.

Lee-Sherick A, Eisenman K, Sather S, McGranahan A, Armistead P, McGary C Oncogene. 2013; 32(46):5359-68.

PMID: 23474756 PMC: 3898106. DOI: 10.1038/onc.2013.40.